Literature DB >> 1252329

Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma.

S Szymaniec, K James.   

Abstract

The presence of Fc receptors on the surface of cell suspensions obtained from a transplanted isogeneic methylcholanthrene induced murine fibrosarcoma has been investigated by determining the capacity of such cells to form rosettes with antibody coated SRBC. These studies indicate that a large percentage of cells in the tumour had Fc receptors on their surface. The proportion of such cells was increased by reducing the number of cells transplanted, by administering cyclophosphamide to the host, and on occasions by the i.p. injection of C. parvum. It was largely unaffected by the route of tumour cell transplantation or by T cell depletion of the host before transplantation but appeared to decline in older (i.e. larger) tumours. Both phagocytic and non-phagocytic cells had Fc receptors on their surface. The phagocytic population appeared to be affected most by procedures which altered the overall percentage of Fc receptor bearing cells. The Fc receptor bearing tumour cells were separated from those devoid of Fc receptors on the basis of their adherent properties. Upon transplantation to isogeneic hosts both populations gave rise to tumours containing a high percentage of Fc receptor bearing cells. These studies suggest that many of the Fc receptor bearing cells in our tumour are probably infiltrating cells of host origin. Their significance in relation to tumour growth remains to be established.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1252329      PMCID: PMC2024911          DOI: 10.1038/bjc.1976.5

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system.

Authors:  W H McBride; J Dawes; N Dunbar; A Ghaffar; M F Woodruff
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

2.  Antibody in the induction and inhibition of lymphocyte cytotoxicity.

Authors:  I C MacLennan
Journal:  Transplant Rev       Date:  1972

3.  19-Hydroxylated E prostaglandins as the major prostaglandins of human semen.

Authors:  P L Taylor; R W Kelly
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

4.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

Review 5.  The possible biological significance of Fc receptors on mammalian lymphocytes and tumor cells.

Authors:  R S Kerbel; A J Davies
Journal:  Cell       Date:  1974-10       Impact factor: 41.582

Review 6.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

7.  Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomas.

Authors:  R S Kerbel; H F Pross; E V Elliott
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

8.  Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.

Authors:  M F Woodruff; N Dunbar
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

9.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 2.  Fc gamma receptors and cancer.

Authors:  Lydie Cassard; Joël Cohen-Solal; Sophie Camilleri-Broët; Emilie Fournier; Wolf Herman Fridman; Catherine Sautès-Fridman
Journal:  Springer Semin Immunopathol       Date:  2006-11-10

3.  Antibodies to tumour eluates react preferentially with non-lymphoid tumours.

Authors:  J E Boyd; K James
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 4.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

5.  Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.

Authors:  Joel F G Cohen-Solal; Lydie Cassard; Emilie M Fournier; Shannon M Loncar; Wolf Herman Fridman; Catherine Sautès-Fridman
Journal:  Dermatol Res Pract       Date:  2010-06-28

6.  Further studies on antitumour responses induced by short-term pretreatment with syngeneic tumour cells.

Authors:  K James; I Milne; J Merriman; W H McBride
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

7.  Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.

Authors:  A W Thomson; N Cruickshank; E F Fowler
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

8.  Giant-cell tumour of bone: cytological studies.

Authors:  K Kasahara; T Yamamuro; A Kasahara
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

9.  Effect of X-irradiation on host-cell infiltration and growth of a murine fibrosarcoma.

Authors:  R Evans
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

10.  Immunological and biochemical characteristics of acid citrate eluates from tumour cells: a major non-immunoglobulin component.

Authors:  K James; S Davis; J Merriman
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.